Member Info for Latino

Who am I to argue, you’re calling this right for over 6 months! Come across as a bit abrasive to existing holders who are desperate so a bit of humility would not go amiss. Acker on the other hand calling it wrong now all the time, must be in deeper red than every other investor here…guys put your egos aside and listen to Jag might save some money left!

She is co-owner and very attached here, but MUST realise she is a Dr and not a CEO. Has done incredible damage to shareholders / investors inadvertently. No shareholder value is being built even after 2 deals with a large pharma like J&J (for many small pharma companies can only dream of), this SP has been decimated once again to new low of the lows. Should not be happening.

The other co-owner is Laurie Keefer, must intervene and talks to Dr Marla. About time they build this company and get major IIs on board.

Next week is too early but it’s coming reckon after Easter, gives them time to suck more investors in. GH said needs -$6.2M in Dec, raised some $2.5M..so simple maths still needs to raise another ~$4.7m (at least if cost do not spiral) to meet target. It’s never ending conundrum for investors!

Agree but squeeky bum time now, should not be retreating if licence is due. Indonesia gov losing all credibility here, as struggling to meet their timescales.

Nope it’s clinical trials and they’ve kept this quite until now, so this could be with another major pharma company. They’re already working in a limited capacity with Pfizer, AstraZeneca and ICON, so good chance it’s any one of these? These prices (lowest ever SP) could be a steal in coming weeks but as always DYOR and also listen to the derampers for a balanced view as it’s high risk / high reward now!

Missed this, as it’s way at the bottom of RNS. CEO has also confirmed £5M facility still intact (of which they have around £4.5M still available)

‘The Company has continued to reduce its monthly cash burn to an average of c. $300k as of March 2026, and expects its cash runway to extend into early April 2026. In addition, the Company is progressing discussions regarding a potential loan from certain Directors and will update the market as appropriate. The Convertible Facility provided by Alumni Capital LLC remains in place, although utilisation is currently constrained by market conditions.’

Not a chance say derampers lol…wasn’t it supposed to go to a wall today or by end of March! Now MSA signed, late stage collaboration discussions happening right now AND they’ve told you Director Loan coming! Also don’t worry about banks being open, the directors are also co-owners…and READ they’ve said ‘early April’ does not mean next week…it’s a flexible timescale and so they’re relaxed!

Director Loan + the £5M facility they have signed in Jan 26 is still there, but CEO doing right thing as it’s dilutive, so don’t want to draw down more!

12 month facility of up to £5 million in principal, available in multiple tranches;

Well according to derampers they were out of money today! Derampers surely don’t want to read…it’s coming and they continue making deals and a major collaboration is in final stages…AND they have told you they’re going to fund this themselves vi. loan which will be ‘non-dilutive funding’

Key Extract: 'it further validates the strength and differentiation of the Company's TrialSet™ offering in the clinical trial sector and establishes a framework for future commercial opportunities. It also enables each party access to each other's client base through opportunities to co-market. The Company is also progressing advanced late stage discussions regarding an additional clinical trial collaboration and will update the market in due course.

MSA signed looks like future cash generation as its will set a future commercial framework. ALSO hint another major collaboration discussions in late / advanced stage..J&J/AstraZeneca/ICON/Pfizer/?? Company going to the wall does not embark on such major negotiations!

Director loan coming…and it’s NON-DILUTIVE funding, great news directors (co-owners) are preparing to fund this…also cash-burn reduced again is good news. Naysayers who said this is finished lol

Who envisaged a drop of this proportion after J&J deal…no one! went to 2p and now way lower than it was before this deal @0.25. It’s unbelievable and shows this is being run by a Dr and not a business leader. CEO is also co-owner so needs to realise the damage she’s doing to investors and shareholders!

Rumour??

No RNS, SP now being wacked down day after day to its lowest ever. But still no word or update from Dr Marla, total disregard of shareholders / investors. This is not acceptable, next AGM needs to step down or push out..can’t go on like this!

Many dermapers have been scaremongering investors of delisting last few months, admin etc. Well it’s clear from the results, it’s not and green shoots of progress, advancing and moving forward.

Interesting, finally making breakthroughs?

Extract: ‘Advancing contract discussion with major US diagnostic companies to provide kidneyintelX.dkd with broad, national distribution and reduction in logistics cost for blood sample transport’

You’d better run over to FCM quick lol

Was it not a US based II who invested some $4.5M here a few years ago…so reckon US IIs are circling..

Could they also be a bid coming from US…SP rising from lower ever and US had identified ZIRCON as a strategic asset. So it’s an ideal time for a US firm to move in!